Des Plaines, IL - A new study that investigates low-dose ketamine (LDK) as an adjunct to morphine for treating acute pain has ...

Title: ALG-055009, a Novel Thyroid Hormone Receptor Beta (THR-ß) Agonist, was Well-tolerated with Significant Reductions in Liver Fat at Week 12 in Non-cirrhotic MASH Patients in the Ongoing ...

Superstar Shah Rukh Khan has announced the directorial debut of his son Aryan Khan. The special untitled Bollywood series is ...

Medically reviewed by Soma Mandal, MD High blood pressure (hypertension) can lead to serious complications like heart attack ...

Twelve months after two 16 mg doses of the drug, called CYB003, seven patients saw their scores improve on the ...

Researchers have tested a novel therapeutic concept to treat virus-induced lung failure in patients with severe COVID-19 in a phase 2 clinical trial. The approach may also be applicable to other ...

Spokane, Washington - Vanessa R. Waldref, United States Attorney for the Eastern District of Washington, announced that ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good morning, ladies and gentlemen, and welcome to the Protalix ...

Research and development expenses were $2.6 million for the three months ended September 30, 2024, compared to $1.1 million for the same period in 2023. The increase was primarily attributable to ...

REL-P11 is a proprietary, low-dose, modified-release psilocybin formulationSingle-Ascending Dosing (SAD) study to evaluate safety and ...